Distinct microRNA expression profiles in acute myeloid leukemia with common translocations Z Li, J Lu, M Sun, S Mi, H Zhang, RT Luo, P Chen, Y Wang, M Yan, Z Qian, ... Proceedings of the National Academy of Sciences 105 (40), 15535-15540, 2008 | 580 | 2008 |
Protein ISGylation modulates the JAK-STAT signaling pathway OA Malakhova, M Yan, MP Malakhov, Y Yuan, KJ Ritchie, KI Kim, ... Genes & development 17 (4), 455-460, 2003 | 400 | 2003 |
A previously unidentified alternatively spliced isoform of t (8; 21) transcript promotes leukemogenesis M Yan, E Kanbe, LF Peterson, A Boyapati, Y Miao, Y Wang, IM Chen, ... Nature medicine 12 (8), 945-949, 2006 | 344 | 2006 |
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection KJ Ritchie, CS Hahn, KI Kim, M Yan, D Rosario, L Li, JC de la Torre, ... Nature medicine 10 (12), 1374-1378, 2004 | 322 | 2004 |
Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t (8; 21) leukemia in … GB Zhou, H Kang, L Wang, L Gao, P Liu, J Xie, FX Zhang, XQ Weng, ... Blood 109 (8), 3441-3450, 2007 | 286 | 2007 |
Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43 M Sarasin-Filipowicz, X Wang, M Yan, FHT Duong, V Poli, DJ Hilton, ... Molecular and cellular biology 29 (17), 4841-4851, 2009 | 210 | 2009 |
Cosegregation of C‐insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss R Li, G Xing, M Yan, X Cao, XZ Liu, X Bu, MX Guan American Journal of Medical Genetics Part A 124 (2), 113-117, 2004 | 191 | 2004 |
STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling K Arimoto, S Löchte, SA Stoner, C Burkart, Y Zhang, S Miyauchi, S Wilmes, ... Nature structural & molecular biology 24 (3), 279-289, 2017 | 185 | 2017 |
Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development M Yan, SA Burel, LF Peterson, E Kanbe, H Iwasaki, A Boyapati, R Hines, ... Proceedings of the National Academy of Sciences 101 (49), 17186-17191, 2004 | 171 | 2004 |
Acute myeloid leukemia with the 8q22; 21q22 translocation: secondary mutational events and alternative t (8; 21) transcripts LF Peterson, A Boyapati, EY Ahn, JR Biggs, AJ Okumura, MC Lo, M Yan, ... Blood, The Journal of the American Society of Hematology 110 (3), 799-805, 2007 | 160 | 2007 |
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells D Ran, WJ Shia, MC Lo, JB Fan, DA Knorr, PI Ferrell, Z Ye, M Yan, ... Blood, The Journal of the American Society of Hematology 121 (15), 2882-2890, 2013 | 154 | 2013 |
PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential WJ Shia, AJ Okumura, M Yan, A Sarkeshik, MC Lo, S Matsuura, ... Blood, The Journal of the American Society of Hematology 119 (21), 4953-4962, 2012 | 143 | 2012 |
Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling KI Kim, M Yan, O Malakhova, JK Luo, MF Shen, W Zou, JC De La Torre, ... Molecular and cellular biology, 2006 | 139 | 2006 |
USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1–TAB1 complex X Liu, H Li, B Zhong, M Blonska, S Gorjestani, M Yan, Q Tian, DE Zhang, ... Journal of experimental medicine 210 (8), 1575-1590, 2013 | 118 | 2013 |
SRSF2 is essential for hematopoiesis, and its myelodysplastic syndrome-related mutations dysregulate alternative pre-mRNA splicing Y Komeno, YJ Huang, J Qiu, L Lin, YJ Xu, Y Zhou, L Chen, ... Molecular and cellular biology 35 (17), 3071-3082, 2015 | 114 | 2015 |
Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis JB Fan, K Arimoto, K Motamedchaboki, M Yan, DA Wolf, DE Zhang Scientific reports 5 (1), 12704, 2015 | 106 | 2015 |
Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling KI Kim, OA Malakhova, K Hoebe, M Yan, B Beutler, DE Zhang The Journal of Immunology 175 (2), 847-854, 2005 | 99 | 2005 |
The p21Waf1 pathway is involved in blocking leukemogenesis by the t (8; 21) fusion protein AML1-ETO LF Peterson, M Yan, DE Zhang Blood 109 (10), 4392-4398, 2007 | 90 | 2007 |
RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis M Yan, EY Ahn, SW Hiebert, DE Zhang Blood, The Journal of the American Society of Hematology 113 (4), 883-886, 2009 | 69 | 2009 |
Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis EY Ahn, M Yan, OA Malakhova, MC Lo, A Boyapati, HB Ommen, R Hines, ... Proceedings of the National Academy of Sciences 105 (44), 17103-17108, 2008 | 66 | 2008 |